MedTrace Logo

Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology

NCT06788821 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2025-01-29

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the possibility to use prenatal ultrasonography for diagnosis and prognostic guidance in cases of suspected fetal thyroid changes in fetuses belonging to women with thyroid disease and women with low obstetric risk (i.e., pregnancy not complicated by maternal and/or fetal pathology) between 14 and 37 gestational weeks.

The main question it aims to answer is:

Is it possible to diagnose thyroid disease in fetuses early using measurable parameters of the fetal thyroid through ultrasonography?

Conditions

  • Thyroid Disease Pregnancy

Interventions

DIAGNOSTIC_TEST

Description of the trend of major thyroid ultrasound biometric parameters

Use of prenatal ultrasonography for diagnosis and prognostic guidance in suspected fetal thyroid changes.

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Elena Contro, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-12
Primary Completion
2026-03-01
Completion
2026-03-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06788821 on ClinicalTrials.gov